Mail

UK markets close in 5 hours 37 minutes

FTSE 100
8,434.33
+0.57(+0.01%)
FTSE 250
20,615.52
-29.86(-0.14%)
AIM
789.38
-0.49(-0.06%)
GBP/EUR
1.1618
-0.0004(-0.04%)
GBP/USD
1.2529
+0.0004(+0.03%)
Bitcoin GBP
50,300.50
+1,623.95(+3.34%)

Trending tickers: Alibaba, Bitcoin, SoftBank and Diploma

The latest investor updates on stocks that are trending on Monday

Radiopharm Theranostics Limited (RDPTF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0008

0.0000

(0.00%)

At close: 09:37AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	11.88M
Enterprise value	10.64M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.02
Enterprise value/revenue	-404.78
Enterprise value/EBITDA	0.17

Trading information

Stock price history

Beta (5Y monthly)	0.98
52-week change ³	-99.11%
S&P500 52-week change ³	26.27%
52-week high ³	0.0900
52-week low ³	0.0008
50-day moving average ³	0.0344
200-day moving average ³	0.0761

Share statistics

Avg vol (3-month) ³	1.15k
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	451.8M
Implied shares outstanding ⁶	14.95B
Float ⁸	231.64M
% held by insiders ¹	39.17%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-469.02%

Management effectiveness

Return on assets (ttm)	-30.84%
Return on equity (ttm)	-107.05%

Income statement

Revenue (ttm)	6.01M
Revenue per share (ttm)	0.02
Quarterly revenue growth (yoy)	-4.60%
Gross profit (ttm)	N/A
EBITDA	-33.39M
Net income avi to common (ttm)	-46.82M
Diluted EPS (ttm)	-0.0900
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.89M
Total cash per share (mrq)	0
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.50
Book value per share (mrq)	0.06

Cash flow statement

Operating cash flow (ttm)	-22.94M
Levered free cash flow (ttm)	-17.75M